Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Chuan Xiong (Ligusticum chuanxiong) is a traditional Chinese herb containing tetramethylpyrazine as its primary bioactive compound. It enhances blood circulation by promoting vasodilation and inhibiting platelet aggregation through calcium channel modulation.
Reported Benefits (Provisional)
Origin & History
Chuan Xiong, also known as Ligusticum chuanxiong, is a perennial herb native to China. It is primarily grown in Sichuan province and is harvested for its rhizomes, which are dried and used in herbal formulations.
Research Narrative (Provisional)
Research on Chuan Xiong includes randomized controlled trials and studies that suggest its efficacy in improving blood circulation and reducing pain. However, more high-quality studies are needed to fully understand its benefits and mechanisms.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Chuan Xiong (Ligusticum chuanxiong) is a medicinal herb rather than a dietary staple, so its nutritional profile is characterized primarily by bioactive phytochemicals rather than conventional macronutrients. Macronutrient content per 100g dried rhizome (approximate): Carbohydrates 55-65g (including polysaccharides such as ligustican and glucans at ~8-12g), Protein 8-12g (including free amino acids: arginine, lysine, proline), Crude fiber 10-15g, Lipids 3-5g (including linoleic acid and palmitic acid). Key bioactive compounds: (1) Phthalides — Z-ligustilide is the dominant compound at approximately 5-15mg/g in dried rhizome, responsible for vasodilatory and neuroprotective effects; senkyunolide A and H present at 0.5-2mg/g; butylidenephthalide at 1-3mg/g. (2) Alkaloids — tetramethylpyrazine (TMP/ligustrazine) at approximately 0.01-0.05mg/g in raw herb, higher in processed forms; acts as a calcium channel modulator. (3) Phenolic acids — ferulic acid at 0.5-1.5mg/g, a potent antioxidant and platelet aggregation inhibitor with moderate oral bioavailability (~30-40% absorbed). (4) Flavonoids — chrysin and apigenin derivatives at trace levels (~0.1-0.3mg/g). (5) Volatile oils comprising 1-2% of dry weight, dominated by Z-ligustilide and cnidilide. Minerals: Potassium (~800-1200mg/100g), Calcium (~200-400mg/100g), Magnesium (~100-200mg/100g), Iron (~10-20mg/100g), Zinc (~2-5mg/100g), Phosphorus (~150-300mg/100g). Vitamins: Limited data; small amounts of B-complex vitamins reported including niacin (~2-4mg/100g) and riboflavin (~0.1-0.3mg/100g). Bioavailability notes: Z-ligustilide is lipophilic and volatile, with bioavailability enhanced by alcohol-based extraction (tinctures) versus water decoction; ferulic acid bioavailability increases with heat processing; tetramethylpyrazine is water-soluble and well-absorbed orally; polysaccharides are largely non-digestible but may exert prebiotic effects. Typical clinical dosage is 3-10g dried rhizome per day as decoction.
Reported Mechanism (Provisional)
Chuan Xiong's primary compound tetramethylpyrazine blocks L-type calcium channels in vascular smooth muscle, promoting vasodilation and improved blood flow. The herb also inhibits thromboxane A2 synthesis and reduces platelet aggregation through cyclooxygenase pathway modulation. Additional phthalide compounds like ligustilide enhance nitric oxide production, further supporting cardiovascular function.
Clinical Narrative (Provisional)
Small-scale clinical trials with 30-60 participants have shown Chuan Xiong extracts can reduce headache frequency by 40-60% compared to placebo over 8-12 week periods. Studies on cardiovascular effects demonstrate modest improvements in blood flow parameters, though most research has been conducted in Asian populations with relatively short follow-up periods. The anti-inflammatory effects have been primarily demonstrated in animal models and in vitro studies, with limited human clinical data. Overall evidence quality is moderate, requiring larger randomized controlled trials for stronger therapeutic claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.